Response and resistance to BET bromodomain inhibitors in triple-negative breast cancerShaokun Shu, Kornélia Polyák, Charles Y. Lin et al.|Nature|2016Cited by 629
Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligandsLara Gechijian, James E. Bradner, Dennis L. Buckley et al.|Nature Chemical Biology|2018Cited by 229
Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast CancerShaokun Shu, Kornélia Polyák, Hua‐Jun Wu et al.|Molecular Cell|2020Cited by 207
Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast ActivationMatthew S. Stratton, Timothy A. McKinsey, Rushita A. Bagchi et al.|Circulation Research|2019Cited by 177
Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancerJennifer Y. Ge, Kornélia Polyák, Shaokun Shu et al.|Nature Communications|2020Cited by 97